Myriad myPath Melanoma Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Myriad myPath Melanoma General Information
Description
Developer of genome tests designed to diagnose melanoma. The company offers gene-based tests for skin cancer diagnosis through improvement amendments certified clinical laboratory improvement amendments certified laboratory, giving the confidence to personalize patient treatment recommendations.
Contact Information
Website
www.mypathmelanoma.comCorporate Office
- 320 Wakara Way
- Salt Lake City, UT 84108
- United States
Corporate Office
- 320 Wakara Way
- Salt Lake City, UT 84108
- United States
Myriad myPath Melanoma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Myriad myPath Melanoma Patents
Myriad myPath Melanoma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220243275-A1 | Genes and gene signature for diagnosis and treatment of melanoma | Inactive | 06-Jan-2016 | ||
| CA-3010240-A1 | Genes and gene signatures for diagnosis and treatment of melanoma | Pending | 06-Jan-2016 | ||
| EP-3400312-A1 | Genes and gene signatures for diagnosis and treatment of melanoma | Inactive | 06-Jan-2016 | ||
| EP-3400312-A4 | Genes and gene signatures for diagnosis and treatment of melanoma | Inactive | 06-Jan-2016 | ||
| US-20190032144-A1 | Genes and gene signatures for diagnosis and treatment of melanoma | Inactive | 06-Jan-2016 | C12Q1/6886 |
Myriad myPath Melanoma Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Myriad myPath Melanoma FAQs
-
Where is Myriad myPath Melanoma headquartered?
Myriad myPath Melanoma is headquartered in Salt Lake City, UT.
-
What industry is Myriad myPath Melanoma in?
Myriad myPath Melanoma’s primary industry is Diagnostic Equipment.
-
Is Myriad myPath Melanoma a private or public company?
Myriad myPath Melanoma is a Private company.
-
What is the current valuation of Myriad myPath Melanoma?
The current valuation of Myriad myPath Melanoma is .
-
What is Myriad myPath Melanoma’s current revenue?
The current revenue for Myriad myPath Melanoma is .
-
Who are Myriad myPath Melanoma’s investors?
Myriad Genetics has invested in Myriad myPath Melanoma.
-
When was Myriad myPath Melanoma acquired?
Myriad myPath Melanoma was acquired on 28-May-2021.
-
Who acquired Myriad myPath Melanoma?
Myriad myPath Melanoma was acquired by Castle Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process